Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance

ADMA Biologics IncTrade
YieldMax Magnificent 7 Fund of Option Income ETFsTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.41. Which is the better fit depends on your goals.

ADMAYMAG
Market Cap
$2.22B
Sector
HealthIncome / Options Overlay
52-Week High
$20.38$15.98
52-Week Low
$7.60$10.76
Enterprise Value
$2.29B

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.

Read more on YMAG